NDRA logo

ENDRA Life Sciences (NDRA)

Profile

Full Name

ENDRA Life Sciences Inc.

Ticker Symbol

NDRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 30, 2017

Indexes

Not included

Website

http://endrainc.com

Employees

21

Key Details

Price

$3.16(+1.94%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$56.94(+97.94% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.16
NDRA price is $3.16

30-Day Relative Volume

0.51
NDRA 30-day relative volume is 0.51

Price Performance

Price Most recent change

+1.94%
NDRA price was up +1.94% on Apr 15, 2025

Price YTD change

-49.52%
NDRA price is down -49.52% since January 1st

Price 1-year change

-99.31%
NDRA price is down -99.31% year-on-year

Price 3-year change

-99.97%
NDRA price is down -99.97% over the past 3 years

Price Range

Price All-time high

$189000.00
NDRA price is currently -100.00% below its historical high of $189000.00

Price 3-year low

$0.07
NDRA price is currently +4761.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.78M
NDRA market capitalization is $1.78 million

Market cap 3-year change

-84.92%
NDRA market capitalization is down -84.92% over the past 3 years

Market cap All-time high

$115.08M
NDRA market capitalization is currently -98.46% below its historical high of $115.08 million

Market cap sector rank

6.25%
NDRA market capitalization is higher than 6.25% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+8967.74%
NDRA shares outstanding is up +8967.74% year-on-year

Shares Outstanding 3-Year Change

+43146.15%
NDRA shares outstanding is up +43146.15% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.82
NDRA beta is 1.82

200-day SMA

$29.47
NDRA price is currently -89.28% below its 200-day simple moving average

50-day SMA

$4.25
NDRA price is currently -25.62% below its 50-day simple moving average

RSI

39.81
NDRA 14-day relative strength index is 39.81

Volume

0.51
NDRA 30-day relative volume is 0.51

ATR

$0.60
NDRA average true range is $0.60

10-day Historical Volatility

253.93%
NDRA 10-day historical volatility is 253.93%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NDRA annual revenue value is unknown

Revenue Analysts estimate

$100.00K
NDRA annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
NDRA annual revenue 1-year change is unknown

Revenue Sector rank

-
NDRA annual revenue is unknown

EPS

EPS

-$56.94
NDRA annual earnings per share is -$56.94

EPS Analysts estimate

-$538.30
NDRA annual earnings per share is currently -89.42% lower than the consensus analysts' forecast

EPS 1-year change

+97.94%
NDRA annual earnings per share is up +97.94% year-on-year

EPS Sector rank

3.72%
NDRA annual earnings per share is higher than 3.72% of companies in Healthcare sector

Profit

Gross profit

-
NDRA annual gross profit value is unknown

Gross margin

-
NDRA annual gross profit margin value is unknown

Operating profit

-$10.82M
NDRA annual operating income is -$10.82 million

Operating margin

-
NDRA annual operating profit margin value is unknown

Net income

-$11.51M
NDRA annual net profit is -$11.51 million

Net margin

-
NDRA annual net profit margin value is unknown

Expenses

Total expenses

$10.82M
NDRA annual total expenses is $10.82 million

Operating expenses

$10.82M
NDRA annual total operating expenses is $10.82 million

Cost of goods sold

-
NDRA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.63M
NDRA annual SGA is $7.63 million

Depreciation and amortization

$206.20K
NDRA annual depreciation & amortization is $206.20 thousand

Interest expense

-
NDRA annual interest expense value is unknown

Income tax

$0.00
NDRA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$10.82M
NDRA annual earnings before interest & taxes is -$10.82 million

EBITDA

-$10.61M
NDRA annual EBITDA is -$10.61 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.45M
NDRA annual total assets is $4.45 million

Non current assets

$1.02M
NDRA annual long term assets is $1.02 million

Current assets

$3.43M
NDRA annual total current assets is $3.43 million

Cash and cash equivalents

$3.23M
NDRA annual cash & cash equivalents is $3.23 million

Accounts receivable

-
NDRA annual accounts receivable value is unknown

Inventory

-
NDRA annual inventory value is unknown

Liabilities

Total liabilities

$1.89M
NDRA annual total liabilities is $1.89 million

Long term liabilities

$1.29M
NDRA annual total long term liabilities is $1.29 million

Current liabilities

$605.20K
NDRA annual total current liabilities is $605.20 thousand

Accounts payable

$269.70K
NDRA annual accounts payable is $269.70 thousand

Debt

Total debt

$584.40K
NDRA annual total debt is $584.40 thousand

Total debt 1-year change

+48.17%
NDRA annual total debt is up +48.17% year-on-year

Long term debt

$487.50K
NDRA annual long term debt is $487.50 thousand

Short term debt

$96.90K
NDRA annual short term debt is $96.90 thousand

Equity & Capital

Shareholders equity

$2.56M
NDRA annual stockholders equity is $2.56 million

Book value

$2.56M
NDRA annual book value is $2.56 million

Retained earnings

-$103.44M
NDRA annual retained earnings is -$103.44 million

Working capital

$2.83M
NDRA annual working capital is $2.83 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$7.40M
NDRA annual cash flow from operations is -$7.40 million

Cash from operations 1-year change

+22.5%
NDRA annual cash flow from operations is up +22.5% year-on-year

Cash from investing

-$12.80K
NDRA annual cash flow from investing activities is -$12.80 thousand

Cash from investing 1-year change

+48.18%
NDRA annual cash flow from investing activities is up +48.18% year-on-year

Cash from financing

$7.81M
NDRA annual cash flow from financing activities is $7.81 million

Cash from financing 1-year change

+3.87%
NDRA annual cash flow from financing activities is up +3.87% year-on-year

CAPEX

CAPEX

-
NDRA annual capital expenditures value is unknown

CAPEX 1-year change

-
NDRA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$7.42M
NDRA annual free cash flow is -$7.42 million

Free cash flow 1-year change

+22.61%
NDRA annual free cash flow is up +22.61% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NDRA annual gross profit margin value is unknown

Operating margin

-
NDRA annual operating profit margin value is unknown

Net margin

-
NDRA annual net profit margin value is unknown

ROA & ROE

ROA

-258.47%
NDRA annual return on assets is -258.47%

ROE

-449.46%
NDRA annual return on equity is -449.46%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NDRA price to earnings ratio value is unknown

PE ratio Sector rank

-
NDRA price to earnings ratio is unknown

PB Ratio

PB ratio

0.69
NDRA price to book ratio is 0.69

PB ratio Sector rank

36.13%
NDRA price to book ratio is higher than 36.13% of companies in Healthcare sector

PS Ratio

PS ratio

-
NDRA price to sales ratio value is unknown

PS ratio Sector rank

-
NDRA price to sales ratio is unknown

Enterprise value

Enterprise value

-$868.55K
NDRA enterprise value is -$868.55 thousand

Enterprise value Sector rank

10.58%
NDRA enterprise value is higher than 10.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.08
NDRA EV/EBITDA is 0.08

EV/EBITDA Sector rank

66.43%
NDRA EV/EBITDA is higher than 66.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.67
NDRA annual current ratio is 5.67

Quick ratio

-
NDRA annual quick ratio value is unknown

Leverage

Debt to equity

0.23
NDRA annual debt to equity ratio is 0.23

Interest coverage ratio

-
NDRA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NDRA piotroski f-score value is unknown

Altman Z-Score

-
NDRA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jun 7, 24 Ascendiant Capital
Buy
Mar 31, 23 HC Wainwright & Co.
Buy
Apr 7, 22 HC Wainwright & Co.
Buy
Jul 15, 19 H.C. Wainwright
Buy
May 20, 19 Lake Street
Buy

Institutional Ownership

Similar stocks

CERO logo
CERo Therapeutics Holdings (CERO)
OMGA logo
Omega Therapeutics (OMGA)
Polyrizon (PLRZ)
AWH logo
Aspira Womens Health (AWH)
ENTO logo
Entero Therapeutics (ENTO)
HSDT logo
Helius Medical Technologies (HSDT)
Scinai Immunotherapeutics (SCNI)
FOXO logo
FOXO Technologies (FOXO)
PBM logo
Psyence Biomedical (PBM)
  • What is the ticker symbol for ENDRA Life Sciences?
  • Does ENDRA Life Sciences pay dividends?
  • What sector is ENDRA Life Sciences in?
  • What industry is ENDRA Life Sciences in?
  • What country is ENDRA Life Sciences based in?
  • When did ENDRA Life Sciences go public?
  • Is ENDRA Life Sciences in the S&P 500?
  • Is ENDRA Life Sciences in the NASDAQ 100?
  • Is ENDRA Life Sciences in the Dow Jones?
  • When was ENDRA Life Sciences's last earnings report?
  • When does ENDRA Life Sciences report earnings?
  • Should I buy ENDRA Life Sciences stock now?

What is the ticker symbol for ENDRA Life Sciences?

The ticker symbol for ENDRA Life Sciences is NASDAQ:NDRA

Does ENDRA Life Sciences pay dividends?

No, ENDRA Life Sciences does not pay dividends

What sector is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Healthcare sector

What industry is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Diagnostics & Research industry

What country is ENDRA Life Sciences based in?

ENDRA Life Sciences is headquartered in United States

When did ENDRA Life Sciences go public?

ENDRA Life Sciences's initial public offering (IPO) was on June 30, 2017

Is ENDRA Life Sciences in the S&P 500?

No, ENDRA Life Sciences is not included in the S&P 500 index

Is ENDRA Life Sciences in the NASDAQ 100?

No, ENDRA Life Sciences is not included in the NASDAQ 100 index

Is ENDRA Life Sciences in the Dow Jones?

No, ENDRA Life Sciences is not included in the Dow Jones index

When was ENDRA Life Sciences's last earnings report?

ENDRA Life Sciences's most recent earnings report was on Mar 31, 2025

When does ENDRA Life Sciences report earnings?

The next expected earnings date for ENDRA Life Sciences is May 14, 2025

Should I buy ENDRA Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page